Drotrecogin alfa
Top View
- Venous Thromboembolism, Coagulation and Cancer Van Doormaal, F.F
- New Therapeutic Options for Patients with Sepsis and Disseminated Intravascular Coagulation
- Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
- 140-239.9 Organ Failure
- Xigris, INN-Drotrecogin Alfa (Activated)
- Drotrecogin Alfa (Activated)
- ICU Resident's Guide
- Deuterated Derivatives of Ticagrelor for Medical Use
- Management of Sepsis
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- Pharmacological Agents Targeting Thromboinflammation in COVID-19
- Update on Antiplatelet Therapy in Cardiovascular Disease
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Drotrecogin Alfa (Activated): a Novel Therapeutic Strategy for Severe Sepsis S M Pastores
- Adjuvent and New Therapeutic Interventions in Septic Shock ?
- Drotrecogin Alfa (Activated), Xigris, Label
- WHO Drug Information Vol
- Lilly and Investor Group Form New Critical Care Company Biocritica, Sign Xigris License Agreement